Infliximab (anti-TNF-alpha), TNF-α 抑制剂

抗体

英夫利昔单抗 | TNFSF2抗体 | TNFSF2单克隆抗体 | TNFSF2药靶抗体 | TNFa抗体 | TNFa单克隆抗体 | TNFa药靶抗体 | TNF抗体 | TNF单克隆抗体 | TNF药靶抗体

Infliximab | Remicade | Remsima | Inflectra | Avakine | CT-P13 | APC1 antibody | APC1 protein antibody | Cachectin antibody | DIF antibody | Differentiation inducing factor antibody | Macrophage cytotoxic factor antibody | Tnf antibody | TNF superfamily m

Liquid

I412009-10mg

10mg

无动物源

≥95%(SDS-PAGE&SEC-HPLC)

>95%

-80℃储存,避免反复冻融

超低温冰袋运输

长期储存-20℃（24个月）；收货后建议分装，避免反复冻融。

Supplied as a 0.22 μm filtered solution in 100mM Pro-AC, 20mM Arg, pH 5.0

No

Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation.

ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)

CHO supernatant

人(Human)

人(Human), 食蟹猴(Cynomolgus monkey) | 人(Human),食蟹猴(Cynomolgus monkey)

TNFSF2/TNFa

170277-31-3

27.6 kDa (Light Chain) & 52.7 kDa (Heavy Chain), under reducing conditions; 186.7 kDa, under non-reducing conditions.

Unconjugated

Human IgG1

重组抗体

kappa

Protein A purified

Primary antibody

抑制剂

TNF-α 抑制剂

Whole IgG